U.S. Markets close in 3 hrs 56 mins

Ra Medical Systems, Inc. (RMED)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.3016+0.0246 (+8.88%)
As of 12:02PM EDT. Market open.

Ra Medical Systems, Inc.

2070 Las Palmas Drive
Carlsbad, CA 92011
United States
760 804 1648

IndustryMedical Devices
Full Time Employees58

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan Will McGuireCEO & Director911.12kN/A1963
Mr. Andrew C. JacksonCFO & Sec.520.7kN/A1969
Ms. Tiah ReppasVP, Chief Accounting Officer & Corp. ControllerN/AN/AN/A
Ms. Maria VillanuevaVP & Compliance OfficerN/AN/AN/A
Mr. Al Memmolo B.S. MBASr. VP of Clinical, Quality & Regulatory AffairsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Corporate Governance

Ra Medical Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.